Kapila Ratnam, Ph.D.
General Partner
Dr. Kapila Ratnam is a Partner of NewSpring and the Firm's dedicated healthcare funds. Dr. Ratnam joined NewSpring in 2007 and has over 20 years of experience in the healthcare industry.
Prior to joining NewSpring, Kapila worked in the health sciences division at PSI International, a firm that provides outsourced services to the pharmaceutical industry and government health service agencies.
Before PSI International, she served as a strategy consultant to early stage pharmaceutical services and biotech companies; and worked in R&D at GlaxoSmithKline Pharmaceuticals, a global healthcare company, that researches, develops, and manufactures innovative pharmaceutical medicines, vaccines, and consumer healthcare products.
Kapila received an MBA from Columbia University and a Ph.D. from The Ohio State University.
Related News
Catalent To Acquire Gene Therapy Leader Paragon Bioservices, Inc. For $1.2 Billion
The growing investment opportunity in urgent care
These 14 investors have urgent tips for your first meeting
How PE can strengthen women’s presence – from a woman on the senior team
Four healthcare sectors turning the heads of PE investors
Artificial intelligence in healthcare: 10 leaders describe the future
What challenges and opportunities does AI pose for healthcare?
The opportunities and challenges of AI in health care
3 healthcare sectors that are grabbing the eye of private equity investors
AI’s biggest challenge will be getting along with physicians